PATENT CLAIM ANALYSIS

Application Number: 16099088
Application Type: Utility
Filing Date: 2018-11
Publication Date: 2019-05
Patent Classification: ["424", "472000"]

Abstract:
A stable tablet-in-tablet pharmaceutical composition having fixed dose combinations of cyclophosphamide and capecitabine and one or more pharmaceutically acceptable excipient. As disclosed is a process for the preparation thereof, and a method their use in treating cancer diseases.

Claim (Index 9):
The stable tablet-in-tablet pharmaceutical composition according to  claim 2 , wherein the outer coat comprising capecitabine granules is prepared by wet granulation method comprising following steps:\n (a) sifting of capecitabine, one or more diluent, a portion of disintegrant through appropriate mesh and mixing in a suitable mixer; (b) dissolving a binder in a solvent to produce a granulation liquid; (c) granulating the dry mixture obtained in step (a) using the granulation liquid of step (b); (d) drying the wet granules obtained in step (c) and optionally screening the dried granules; (e) blending the dried granules obtained in step (d) with remaining portion of disintegrant and sifted glidant; and (f) lubricating the blended granules obtained in step (e) with sifted lubricant to prepare the outer surrounding coat.

Metadata:
- Claim Count in Document: 20.0
- Percentile: 98.0
- Lexical Diversity: 1.10811
- Patent Class: 424.0
- Transitional Phrase Type: open
- Component Type: 1
- Foreign Priority: True
- Related Applications: ['15512946', '12682825', '11475252', '11930644', '13643386']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.6870059574353339
- 35 USC 102 Novelty (BERT): 0.5090326700779861
- Combined Prediction Score: 0.6692086286995991
- Mean Citation Score: 230.019742
- Max Citation Score: 262.29202000000004
- Similarity Product: 189.4949382162476

Labels:
- Claim Label 101: 1
- Claim Label 102: 0
- Claim Label 103: 1
- Claim Label 112: 1
- Combined Label: 0
- Label 101 Adjusted: 1

Dataset: test